We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Early Diagnosis of Osteoarthritis Possible Using MRI

By HospiMedica International staff writers
Posted on 20 Sep 2011
A new method is set to help clinicians diagnose osteoarthritis at such an early stage that it will be possible to delay the progression of the disease by many years, or maybe even stop it entirely. More...


The joint disease osteoarthritis is one of our most common chronic diseases and one of the primary causes of disability for people around the world. “Osteoarthritis often attacks the knee and hip joints and breaks down the impact absorbing cartilage found there. For those affected, the progression of the disease usually takes many years, with gradually increasing pain which often leads to disability,” said Carl Siversson, who has just defended his thesis in medical radiation physics at Lund University (Sweden).

One of the difficulties with osteoarthritis has been diagnosing and tracking the disease before symptoms become evident. It has therefore been difficult to change or delay the course of the disease. Several years ago, researchers from Lund University and Harvard Medical School (Boston, MA, USA) developed a method to measure the degree of osteoarthritis using an MRI scanner, even at a very early stage. The method is called dGEMRIC (delayed gadolinium-enhanced MRI of cartilage).

“This was major progress, but one problem was that the measurements could only be performed in a limited part of the cartilage. We have now improved the method so that we can study all the cartilage in the joint at once. We have achieved this by solving the problem of how to correct all the irregularities in the MRI images,” said Mr. Siversson.

The improved technique has now been assessed both on healthy individuals and on individuals with osteoarthritis, and the findings show that the disease can now be monitored in ways that were not previously possible, according to Mr. Siversson. “Now we are continuing our work to make the method easy for doctors to use in their practice. Our hope is that the method will also be significant for future drug development,” he said, who after completing his PhD will continue his research at Harvard Medical School (Boston, MA, USA).

Related Links:

Lund University
Harvard Medical School




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.